Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Pietro, Fratino"'
Autor:
Pietro Fratino, Cesare Porta, Carmine Gazzaruso, Andrea Rinaldi, R. Paltro, Pasquale Decata, L. Bianchi, P. Protti, Luciano Bernardi
Publikováno v:
International journal of cardiology. 244
Background: Cardiovascular (baroreflex) and respiratory (chemoreflex) control mechanisms were studied separately in diabetes, but their reciprocal interaction (well known for diseases like heart failure) had never been comprehensively assessed. We hy
Publikováno v:
PharmacoEconomics Italian Research Articles. 11:15-23
Administration of Erythropoietin Receptor Agonists (ERAs) is indicated as standard of care for treatment of anaemia in cancer patients. Considering the Italian setting, only limited information is available on the economic impact of ERAs epoetin alfa
Autor:
Arrigo Moglia, Alessandra Repetto, Pietro Fratino, Alfredo Costa, Sabrina Ravaglia, Miriam Rossi, Guy U. Poloni, Anna Pichiecchio, Cesare Danesino
Publikováno v:
Advances in Therapy. 25:820-829
Glycogen storage disease type II (GSDII) is an autosomal recessive myopathy caused by a deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). Enzyme replacement therapy (ERT) with recombinant GAA (rh-GAA) has become available for GSDII, al
Publikováno v:
PharmacoEconomics Italian Research Articles. 10:49-52
Publikováno v:
PharmacoEconomics Italian Research Articles. 9:75-89
Protonic Pump Inhibitors (PPIs) are an innovative class of drugs, effective in the treatment of gastrointestinal acid-related diseases — including those induced by the use of nonsteroidal anti-inflammatory drugs (NSAIDs). With reference to PPIs, th
Autor:
Pietro Fratino, Carlo Cerra
Publikováno v:
PharmacoEconomics Italian Research Articles. 8:119-127
Objective Population aging is matched by an increasing relevance of chronic diseases. According to its supportive approach, the Italian Health Care System (SSN) aims at responding to this area of needs ensuring its own long term financial support. In
Autor:
Adriana Garzaniti, Raffaele Bruno, Sebastiano Bruno Solerte, Carmine Gazzaruso, Arturo Pujia, Pietro Fratino, E De Amici
Publikováno v:
International Journal of Cardiology. 108:354-358
Few and conflicting data are available in the literature on the association between Lp(a) levels and the severity of coronary artery disease (CAD) in diabetic patients. In addition, no studies took into account the role of apo(a) polymorphism. The pu
Publikováno v:
PharmacoEconomics Italian Research Articles. 8:3-17
Cardiovascular diseases remain the major cause of death in the world, with extensive public health expenditures. Lipid lowering agents are widely used for prevention, among which statins are dominant. The statins market is steadily expanding in Italy
Autor:
Cristiana Larizza, Riccardo Bellazzi, Enrique J. Gómez, Pietro Fratino, Ángel Hernández García, Marco Arcelloni, Carmine Gazzaruso, Pasquale Decata, M. Elena Hernando, Pietro Ferrari, Mario Stefanelli
Publikováno v:
Diabetes Technology & Therapeutics. 6:567-578
The junction of telemedicine home monitoring with multifaceted disease management programs seems nowadays a promising direction to combine the need for an intensive approach to deal with diabetes and the pressure to contain the costs of the intervent
Autor:
Carmine Gazzaruso, Adriana Garzaniti, Diego Geroldi, Gianandrea Bertone, Stefano Giordanetti, Emanuela De Amici, Sebastiano Bruno Solerte, Colomba Falcone, Pietro Fratino
Publikováno v:
Circulation. 110:22-26
Background— Erectile dysfunction (ED) is associated with coronary artery disease (CAD). In diabetic patients, CAD is often silent. Among diabetic patients with silent CAD, the prevalence of ED has never been evaluated. We investigated whether ED is